Cognizant teams up with organon to speed delivery of pharmaceutical products and improve women's healthcare

Organon's manufacturing site efficiencies expected to improve supply chain management and speed healthcare product delivery teanack, n.j., july 21, 2022 /prnewswire/ -- cognizant (nasdaq: ctsh) today announced it has signed a new multi-year agreement with organon (nyse: ogn), a global women's health company, to help improve the company's delivery of healthcare products and crucial medicinal supply chain management.
CTSH Ratings Summary
CTSH Quant Ranking